You may know that your surgeon is using the latest minimally invasive technology for your surgery, but how do you know if they've mastered it? To help answer that question, researchers at Keck Medicine of USC looked to a ...
Dec 11, 2017
0
0
Drug overdose was the leading cause of accidental death in the U.S. in 2015. Although pain management after surgery continues to rely on opioids, there are concerns that ubiquitous use of opioids has led to a growing epidemic ...
Oct 25, 2017
0
0
A new study shows a significant improvement in both sexual and urinary function as well as quality of life for hypogonadal men who undergo long-term testosterone replacement therapy.
Aug 15, 2017
0
6
(HealthDay)—The most common complication of prostate biopsy is infection, with mild bleeding also reported, according to an update of the American Urological Association White Paper published in the August issue of The ...
Jul 26, 2017
0
2
(HealthDay)—For men with low-risk prostate cancer, vascular targeted photodynamic therapy achieves an 82 percent rate of absent clinically significant cancer in treated lobes, according to a study published in the August ...
Jul 25, 2017
0
1
(HealthDay)—A white paper has been developed by the American Urological Association Quality Improvement and Patient Safety committee with respect to the diagnosis and management of nonneurogenic chronic urinary retention; ...
Jun 21, 2017
0
0
(HealthDay)—Novel biomarkers have been identified that may have utility for predicting prostate cancer in non-African-American men, according to a study published in the July issue of The Journal of Urology.
Jun 20, 2017
0
0
About 1 in 1,111 patients who undergo urologic surgery for conditions such as prostate cancer and kidney stones experience opioid dependence or overdose (ODO), a Loyola Medicine study has found.
May 30, 2017
0
1
Mayo Clinic researchers have discovered that surgery could more than double life expectancy for many patients with late-stage kidney cancer, giving them anywhere from two to almost 10 years more than they'd have without the ...
Apr 24, 2017
0
2
(HealthDay)—Timing of the first active surveillance biopsy is not associated with increased adverse reclassification of prostate cancer, according to a study published in the April issue of The Journal of Urology.
Apr 22, 2017
0
0
